Genprex announces 1-for-40 reverse stock split effective Feb 2, 2024

Genprex, Inc.

Reverse stock split at 1-for-40 ratio effective 12:01 a.m. ET Feb 2, 2024; trades under symbol GNPX.
Split intended to regain compliance with Nasdaq minimum bid continued listing requirement.
Post-split outstanding shares approx. 1.5 million; fractional shares rounded up to whole share.
No change in par value or authorized shares; all warrants and options adjusted accordingly.
Board approved ratio on Jan 19, 2024, per stockholder authorization from Dec 14, 2023 special meeting.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Genprex, Inc.: Effected a one-for-forty reverse stock split of common stock via a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2024-02-02).

Change: charter amendment
Effective: 2024-02-02

Exact text from the filing

On January 31, 2024, Genprex, Inc. (the “ Company ”) filed a Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware (the “ Certificate of Amendment ”), which will effect, at 12:01 a.m. Eastern Time on February 2, 2024, a one-for-forty (1:40) reverse stock split

View on SEC.gov

Browse all governance changes →

Genprex, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-002620

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.